{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T15:39:24Z","timestamp":1773416364036,"version":"3.50.1"},"reference-count":6,"publisher":"Pan African Medical Journal","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["PAMJ"],"abstract":"<jats:p>Triple-negative breast cancer (TNBC) is an aggressive subtype with high histological grade and an increased propensity for early recurrence. Early locoregional recurrence within three months of a Patey mastectomy is uncommon, making this case noteworthy and contributing valuable insight into the biological aggressiveness of TNBC and the prognostic role of tumor-infiltrating lymphocytes (TILs). We report the case of a 49-year-old postmenopausal woman followed for TNBC at the Mohammed VI Oncology Center in Casablanca, Morocco, who presented with a rapidly enlarging inflammatory mass along the outer edge of the left Patey mastectomy scar, extending toward the axillary tail, three months after surgery. Histopathological evaluation confirmed a locoregional recurrence of invasive carcinoma of no special type, revealing a 12.2 cm grade III tumor with a Ki-67 index of 40%, hormone receptor-negative\/HER2-negative status, and low TILs (10%). The patient received neoadjuvant chemotherapy, followed by surgical excision of the recurrent lesion, radiotherapy and adjuvant chemotherapy consisting of capecitabine, vinorelbine, and gemcitabine, with good tolerance and no evidence of distant metastasis during follow-up. This case underscores the prognostic impact of low TILs and highlights the importance of considering the tumor microenvironment in risk stratification and personalized management of TNBC.<\/jats:p>","DOI":"10.11604\/pamj.2025.52.161.50434","type":"journal-article","created":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T05:36:44Z","timestamp":1769751404000},"source":"Crossref","is-referenced-by-count":0,"title":["Locoregional recurrence of triple-negative breast cancer with low tumor-infiltrating lymphocytes: a case report"],"prefix":"10.11604","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-3786-5099","authenticated-orcid":false,"given":"Khadija","family":"Khadiri","sequence":"first","affiliation":[{"name":"Laboratory of Integrative Biology, Faculty of Sciences Ain Chock, Hassan II University of Casablanca, Casablanca, Morocco"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-6506-1283","authenticated-orcid":false,"given":"Zineb","family":"Khadrouf","sequence":"additional","affiliation":[{"name":"Laboratory of Integrative Biology, Faculty of Sciences Ain Chock, Hassan II University of Casablanca, Casablanca, Morocco"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Malak","family":"Sadry","sequence":"additional","affiliation":[{"name":"Department of Pathology, Ibn Rochd University Hospital, Casablanca, Morocco"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amina","family":"Essalihi","sequence":"additional","affiliation":[{"name":"Laboratory of Cellular and Molecular Pathology, Faculty of Medicine and Pharmacy of Casablanca, Hassan II University of Casablanca, Casablanca, Morocco"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5449-6716","authenticated-orcid":false,"given":"Oumaima","family":"Bouchra","sequence":"additional","affiliation":[{"name":"Laboratory of Cellular and Molecular Pathology, Faculty of Medicine and Pharmacy of Casablanca, Hassan II University of Casablanca, Casablanca, Morocco"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-8940-8787","authenticated-orcid":false,"given":"Majda Taoudi","family":"Benchekroun","sequence":"additional","affiliation":[{"name":"Laboratory of Integrative Biology, Faculty of Sciences Ain Chock, Hassan II University of Casablanca, Casablanca, Morocco"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6857-7442","authenticated-orcid":false,"given":"Mehdi","family":"Karkouri","sequence":"additional","affiliation":[{"name":"Department of Pathology, Ibn Rochd University Hospital, Casablanca, Morocco"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"4870","published-online":{"date-parts":[[2025,12,16]]},"reference":[{"key":"ref0","doi-asserted-by":"crossref","unstructured":"Khadiri K, Khadrouf Z, Mellouki A, Bouchra O, Essalihi A, Naya A et al. Epidemiological and molecular profile of breast cancer: a retrospective study in Casablanca, Morocco. Pan Afr Med J. 2025 Apr 22;50:105. PubMed | Google Scholar DOI: 10.11604\/pamj.2025.50.105.43868","DOI":"10.11604\/pamj.2025.50.105.43868"},{"key":"ref1","doi-asserted-by":"crossref","unstructured":"Schmid P, Cortes J, Dent R, Pusztai L, McArthur H, K\u00fcmmel S et al. Event-free Survival with Pembrolizumab in Early Triple-Negative Breast Cancer. N Engl J Med. 2022 Feb 10;386(6):556-567. PubMed | Google Scholar DOI: 10.1056\/NEJMoa2112651","DOI":"10.1056\/NEJMoa2112651"},{"key":"ref2","doi-asserted-by":"crossref","unstructured":"Cai SL, Liu JJ, Liu YX, Yu SH, Liu X, Lin XQ et al. Characteristics of recurrence, predictors for relapse and prognosis of rapid relapse triple-negative breast cancer. Front Oncol. 2023 Feb 16;13:1119611. PubMed | Google Scholar DOI: 10.3389\/fonc.2023.1119611","DOI":"10.3389\/fonc.2023.1119611"},{"key":"ref3","doi-asserted-by":"crossref","unstructured":"Obeagu EI, Obeagu GU. Lymphocyte infiltration in breast cancer: a promising prognostic indicator. Medicine (Baltimore). 2024 Dec 6;103(49):e40845. PubMed | Google Scholar DOI: 10.1097\/MD.0000000000040845","DOI":"10.1097\/MD.0000000000040845"},{"key":"ref4","doi-asserted-by":"crossref","unstructured":"Toss A, Venturelli M, Civallero M, Piombino C, Domati F, Ficarra G et al. Predictive factors for relapse in triple-negative breast cancer patients without pathological complete response after neoadjuvant chemotherapy. Front Oncol. 2022 Dec 1:12:1016295. PubMed | Google Scholar DOI: 10.3389\/fonc.2022.1016295","DOI":"10.3389\/fonc.2022.1016295"},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"Gao G, Wang Z, Qu X, Zhang Z. Prognostic value of tumor-infiltrating lymphocytes in patients with triple-negative breast cancer: a systematic review and meta-analysis. BMC Cancer . 2020 Mar 4;20(1):179. PubMed | Google Scholar DOI: 10.1186\/s12885-020-6668-z","DOI":"10.1186\/s12885-020-6668-z"}],"container-title":["Pan African Medical Journal"],"original-title":[],"deposited":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T12:29:31Z","timestamp":1773404971000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.panafrican-med-journal.com\/content\/article\/52\/161\/full\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,16]]},"references-count":6,"URL":"https:\/\/doi.org\/10.11604\/pamj.2025.52.161.50434","relation":{},"ISSN":["1937-8688"],"issn-type":[{"value":"1937-8688","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,16]]},"article-number":"50434"}}